Frédéric Lamoth

13.4k citations
187 papers · 9.9k · 7 hit papers · h-index 45

Impact in

Papers in

    • Antifungal resistance and susceptibility 118
    • SARS-CoV-2 and COVID-19 Research 10
    • COVID-19 Clinical Research Studies 7
    • Cytomegalovirus and herpesvirus research 7

Frédéric Lamoth

182 papers receiving 9.7k citations

Frédéric Lamoth's Hit Papers

Primary antifungal prophylaxis in hematological malignancies. Updated clinical practice guidelines by the European Conference on Infections in Leukemia (ECIL) 2025 · 24 citations
240+3+6Years since publication5001k1.5k2k

Peers

Frédéric Lamoth
Comparison fields: 5 of 121
  • Infectious Diseases 7.1k
  • Clinical Biochemistry 186
  • Epidemiology 1.1k
  • Microbiology 29
  • Applied Microbiology and Biotechnology 73
Replace Bart J. A. Rijnders with:
Bart J. A. Rijnders Netherlands
Mindy G. Schuster United States
Markus Ruhnke Germany
Annette C. Reboli United States
Koichi Izumikawa Japan
Yoshitsugu Miyazaki Japan
Elias J. Anaissie United States
Robert Krause Austria
Barbara Dudley Alexander United States
Sebastiaan J. van Hal Australia
Frédéric Lamoth relative to Bart J. A. Rijnders Netherlands Bart J. A. Rijnders's profile →
Citations per field
00.5×1.6×
Bart J. A. Rijnders · 1×
Citations per year

Countries citing papers authored by Frédéric Lamoth

Since Specialization
Citations

This map shows the geographic impact of Frédéric Lamoth's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Frédéric Lamoth with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Frédéric Lamoth more than expected).

Fields of papers citing papers by Frédéric Lamoth

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Frédéric Lamoth. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Frédéric Lamoth. The network helps show where Frédéric Lamoth may publish in the future.

Co-authors

The 25 scholars most cited alongside Frédéric Lamoth, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.

Border = papers with Frédéric Lamoth Line = papers co-authored together Frédéric Lamoth links everyone, so they are left out of the graph.

All Works

20 of 20 papers shown

Showing the 20 most-cited of 187 papers — load more, or switch the sort, to bring in the rest.

#Work
1
Revision and Update of the Consensus Definitions of Invasive Fungal Disease From the European Organization for Research and Treatment of Cancer and the Mycoses Study Group Education and Research Consortium
Hit paper breakdown →
20192149
2
Global guideline for the diagnosis and management of mucormycosis: an initiative of the European Confederation of Medical Mycology in cooperation with the Mycoses Study Group Education and Research Consortium
Hit paper breakdown →
20191223
3
Changes in the epidemiological landscape of invasive candidiasis
Hit paper breakdown →
2017434
4 2011247
5 2020243
6 2011230
7 2013175
8 2010154
9 2016143
10 2020139
11 2017133
12 2012121
13 2020121
14
Invasive Fungal Diseases in Adult Patients in Intensive Care Unit (FUNDICU): 2024 consensus definitions from ESGCIP, EFISG, ESICM, ECMM, MSGERC, ISAC, and ISHAM
Hit paper breakdown →
2024111
15 2017108
16 2019106
17 2014103
18 2009102
19 201099
20 202098

About Frédéric Lamoth

Frédéric Lamoth is a scholar working on Infectious Diseases, Epidemiology, Oncology, Pharmacology and Transplantation, having authored 187 papers that have together received 9.9k indexed citations. Recurring topics across this work include Antifungal resistance and susceptibility (118 papers), SARS-CoV-2 and COVID-19 Research (10 papers), Fungal and yeast genetics research (8 papers), Antibiotics Pharmacokinetics and Efficacy (7 papers), Cytomegalovirus and herpesvirus research (7 papers), COVID-19 Clinical Research Studies (7 papers), Neutropenia and Cancer Infections (6 papers) and Heat shock proteins research (4 papers). The work is most often cited by research in Infectious Diseases (7.1k citations), Clinical Biochemistry (186 citations), Epidemiology (1.1k citations), Microbiology (29 citations) and Applied Microbiology and Biotechnology (73 citations). Frédéric Lamoth has collaborated with scholars based in Switzerland, United States and France. Frequent co-authors include Thierry Calandra, William J. Steinbach, Praveen R. Juvvadi, Barbara Dudley Alexander, Oscar Marchetti, Dimitrios P. Kontoyiannis, Elizabeth L. Berkow, Shawn R. Lockhart, Gilbert Greub and Emmanouil Glampedakis. Their work appears in journals such as Antimicrobial Agents and Chemotherapy, Clinical Infectious Diseases, Open Forum Infectious Diseases, Journal of Antimicrobial Chemotherapy and Clinical Microbiology and Infection.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact